Mikhail Blagosklonny currently serves as the professor of oncology in an institution known as Roswell Park Cancer Institute in the US. Mikhail acquired this position in the year 2009, and he has worked very hard to bring changes in cancer research. Before obtaining this position, Mikhail was serving a senior scientist in an organization referred to as Ordway Research Institute in New York.
Before his appointment as the senior scientist, Mikhail was working as the associate professor of medicine at New York Medical College. His accomplishments in this institution have played a crucial role in his career. Mikhail Blagosklonny is also the chief editor for one of the most respected scientific journals in the world, known as Oncotarget. The successful scientist is an important party in the journal, and he plays a major role in cell death and differentiation department.
Mikhail is also working as an associate editor for cancer therapy and biology in Oncotarget. Apart from these positions, the scientist serves as the chief editor and founder editor for a prominent journal in the medical world known as Cell Cycle. His academic background has played a key role in his success. Read more about Mikhail at LinkedIn
Mikhail Blagosklonny went for his higher education at the well-known First Pavlov State University, located in St Petersburg where he specialized in internal medicine. Later on, he acquired his Ph.D., specializing in cardiology and experimental medicine. His role in aging and cancer research has earned him a lot of respect in the world.
Mikhail is also famed for his advocacy for the use of a cancer drug known as Rapamycin. According to Mikhail, the drug elongates the life of human being. The successful scientist has done a lot of research on cancer therapies and mechanisms of aging. In a recent publication, Mikhail proposes the use of Rapamycin for anti-aging.
Mikhail Blagosklonny has several publications under his name. Reports indicate that the scientist has written over three hundred papers. He has also recorded over twenty-five thousand citations. It is evident that the scientist has transformed the lives of many people who have cancer. He has also assisted many physicians in his career. Visit ResearchGate.Net to learn more about Mikhail’s latest work.